The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells

https://doi.org/10.1016/j.ijpharm.2011.04.067Get rights and content

Abstract

Cell-penetrating peptides (CPPs) can translocate through the plasma membrane and localize in different cell compartments providing a promising delivery system for peptides, proteins, nucleic acids, and other products. Here we describe features of a novel cell-penetrating peptide derived from the intermediate filament protein vimentin, called Vim-TBS.58-81. We show that it enters cells from a glioblastoma line via endocytosis where it distributes throughout the cytoplasm and nucleus. Moreover, when coupled to the pro-apoptogenic peptide P10, it localizes to the nucleus inhibiting cell proliferation. Thus, the Vim-TBS.58-81 peptide represents an effective vector for delivery of peptides and potentially a broad range of cargos to the nucleus.

Introduction

The first cell-penetrating peptide (CPP) was described more than 20 years ago launching the concept of protein transduction domains. Frankel and Pabo (1988) showed that the transactivating Tat protein of HIV-1 can cross the plasma membrane and activate a viral promoter. Thereafter, the group of Lebleu identified Tat amino acids 48–60 as the minimal sequence with capacity to enter cells (Vives et al., 1997). The Tat.48-60 peptide was shown later to translocate through the plasma membrane and localize to the nuclei of glioma cells like U251, T98G (glioblastoma, grade IV) and U373 (astrocytoma, grade III) (Baker et al., 2007, Darbinian et al., 2001, Lo and Wang, 2008).

Peptides able to enter neurons and localize to nuclei also have been described including penetratin, corresponding to the third helix of Antennapedia homeodomain (Derossi et al., 1994). To deliver oligonucleotides to the nucleus, Morris et al. (1997) used the artificial CPP, MPG that contains a hydrophobic domain derived from the fusion sequence of HIV gp41 and a hydrophilic domain derived from the nuclear localization sequence of SV40 T-antigen. Futaki et al. (2001) demonstrated that chimeric cationic peptides, composed of several arginines (called polyArg: 8 or 9 Arg residues) also were able to deliver different molecules into cells. Such CPPs have been used to transport a variety of cargos including oligonucleotides (Astriab-Fisher et al., 2002), liposomes (Torchilin et al., 2003), complete proteins (Snyder and Dowdy, 2005) and protein fragments (Niesner et al., 2002) into different cellular compartments.

We demonstrated previously that intermediate filaments have the capacity to bind unpolymerized tubulin at discrete tubulin-binding sites (TBSs). Peptides corresponding to some of these TBS, like the NFL derived NFL-TBS.40-63 peptide, are able to enter glioma cells where they disrupt the microtubule network and induce apoptosis (Bocquet et al., 2009). In this report we describe the properties of another TBS peptide, Vim-TBS.58-81, derived from the intermediate filament, vimentin. Vim-TBS.58-81 enters T98G human glioblastoma cells and distributes to both the cytoplasmic and the nuclear compartments. However, it does not affect the microtubule network. Using well-established cell biology techniques (Richard et al., 2003), we show that Vim-TBS.58-81 enters cells by an energy dependant process. Additionally, we ligated the Vim-TBS.58-81 peptide to the P10 peptide, a pro-apoptogenic fragment of p21/WAF1 protein (Baker et al., 2007, Mutoh et al., 1999, Warbrick et al., 1995), and show that it crosses the plasma membrane and localizes to the nucleus where P10 maintains its pro-apoptogenic activity. In contrast, when the P10 peptide was ligated to the Tat.48-60 peptide, entry to the nucleus was strongly reduced and its pro-apoptogenic activity was attenuated. These results demonstrate that Vim-TBS.58-81 can be a useful vector capable of maintaining the desirable properties of certain molecular cargos.

Section snippets

Materials

Labeled peptides were synthesized by Millegen (Toulouse). Human glioma T98G cells were obtained from ATCC (Manassa, VA, USA). Cells were cultured in 60 mm dishes at 37 °C under 5% CO2 in DMEM (Lonza, France) supplemented with 10% fetal calf serum, 5% l-glutamine (Lonza, France) and 5% penicillin/streptomycin (Lonza, France) and passaged every 2–3 days.

Immunocytochemistry and fluorescence microscopy

Cells were plated on coverslips one night before experiment, and cultured in medium containing biotinylated peptides for 6 h. After washing in PBS,

Vim-TBS.58-81 and Tat.48-60 peptides distribute to the cytoplasm and nuclei of T98G cells

We demonstrated previously that the NFL derived NFL-TBS.40-63 peptide is internalized by T98G cells where it remains in the cytoplasm and disrupts the microtubule cytoskeleton (Bocquet et al., 2009). Here, to determine if a tubulin binding peptide derived from another intermediate filament has the same properties, we evaluated Vim-TBS.58-81. Both NFL-TBS.40-63 and Vim-TBS.58-81 were readily detectable in T98G cells by fluorescence microscopy, following a 6 h incubation. In contrast to the

Discussion

In this study, we investigated the features of the tubulin binding peptide (Vim-TBS.58-81) derived from the intermediate filament protein vimentin (Bocquet et al., 2009). Like other TBS peptides derived from the diverse family of intermediate filament proteins, it is internalized by T98G glioblastoma cells. Once internalized, it translocates to the nuclear compartment though an unknown mechanism and its interactions, if any, with endogenous nuclear components remain to be illuminated. However,

Acknowledgements

This study was supported by grants from ARC (Association pour la Recherche sur le Cancer), AFM (Association Française contre les Myopathies), and INCa (Institut National du Cancer) to J. Eyer. J. Balzeau was supported by la Region des Pays de la Loire. We thank Emilie Lauret (INSERM U694) for her help with confocal microscopy.

References (31)

  • P. Traub et al.

    The interaction in vitro of the intermediate filament protein vimentin with naturally-occurring RNAs and DNAs

    J. Biol. Chem.

    (1983)
  • E. Vives et al.

    A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus

    J. Biol. Chem.

    (1997)
  • E. Warbrick et al.

    A small peptide inhibitor of DNA-replication defines the site of interaction between the cyclin-dependant kinase inhibitor p21(WAF1) and proliferating cell nuclear antigen

    Curr. Biol.

    (1995)
  • P.G. Yancey et al.

    Cellular cholesterol effect mediated by cyclodextrins—demonstration of kinetic pools and mechanism of efflux

    J. Biol. Chem.

    (1996)
  • A. Astriab-Fisher et al.

    Conjugates of antisense oligonucleotides with the Tat and Antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions

    Pharm. Res.

    (2002)
  • Cited by (22)

    • Peptide and protein in therapeutics

      2023, Peptide and Protein Drug Delivery Using Polysaccharides
    • Epoxiconazole caused oxidative stress related DNA damage and apoptosis in PC12 rat Pheochromocytoma

      2022, NeuroToxicology
      Citation Excerpt :

      100 comets from each slide were visually counted based on the intensity of fluorescence in the tail and reported into five classes. The assay was performed according to the original method of Balzeau et al. (2012) and as described in detail by Hamdi et al. (2019). In order to visualize the cytoskeleton organization (Microtubules, Microfilaments and Intermediate filaments), we have used the alpha-tubulin antibody, fluorescent phalloidin conjugate solution and vimentin antibody respectively.

    • Neuroprotective effects of Myricetin on Epoxiconazole-induced toxicity in F98 cells

      2021, Free Radical Biology and Medicine
      Citation Excerpt :

      F98 cells were grown in 24-well plates containing coverslips and exposed at 37 °C for 24 h to EPX alone or combined to MYR (10, 20, and 50 μM). After the treatment period, the assay was performed according to the original procedure of Balzeau et al. (2012) [47], as described in detail elsewhere [3]. Images were taken with an Olympus Confocal Microscope (BX50) after incubation of cells with anti-Alpha-Tubulin antibody or anti-mouse Vimentin antibody and revelation with an anti-mouse Alexa antibody (568 nm).

    View all citing articles on Scopus
    View full text